American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Texas Instruments
TXN
|
+$416M |
| 2 |
PepsiCo
PEP
|
+$370M |
| 3 |
Aptiv
APTV
|
+$289M |
| 4 |
Johnson & Johnson
JNJ
|
+$283M |
| 5 |
NXP Semiconductors
NXPI
|
+$274M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Value ETF
IWD
|
+$339M |
| 2 |
INXN
Interxion Holding N.V.
INXN
|
+$320M |
| 3 |
Apple
AAPL
|
+$239M |
| 4 |
Booz Allen Hamilton
BAH
|
+$236M |
| 5 |
Roper Technologies
ROP
|
+$220M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.12% |
| 2 | Financials | 16.35% |
| 3 | Healthcare | 15.09% |
| 4 | Consumer Discretionary | 11.64% |
| 5 | Industrials | 9.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Onto Innovation
ONTO
$20.6B
| $1.53M | ﹤0.01% |
41,946
-144,784
| -78% | -$4.92M |
|
1002
Coca-Cola Consolidated
COKE
$12.6B
| $1.53M | ﹤0.01% |
53,730
-175,550
| -77% | -$4.91M |
|
|
KBAL
1003
DELISTED
Kimball International
KBAL
| $1.53M | ﹤0.01% |
73,808
-49,739
| -40% | -$1.03M |
|
|
INVX
1004
Innovex International
INVX
$2.13B
| $1.52M | ﹤0.01% |
+32,504
| New | +$1.49M |
|
|
GLDD
1005
DELISTED
Great Lakes Dredge & Dock
GLDD
| $1.52M | ﹤0.01% |
134,464
-344,524
| -72% | -$3.68M |
|
1006
Central Garden & Pet Co Class A
CENTA
$2.43B
| $1.52M | ﹤0.01% |
64,681
-43,703
| -40% | -$982K |
|
1007
Otter Tail
OTTR
$3.87B
| $1.52M | ﹤0.01% |
29,623
-86,370
| -74% | -$4.48M |
|
1008
Enterprise Financial Services Corp
EFSC
$2.41B
| $1.52M | ﹤0.01% |
31,485
-98,748
| -76% | -$4.38M |
|
1009
Myriad Genetics
MYGN
$309M
| $1.52M | ﹤0.01% |
55,701
-84,668
| -60% | -$2.33M |
|
1010
Fabrinet
FN
$20.5B
| $1.5M | ﹤0.01% |
+23,067
| New | +$1.33M |
|
|
EGOV
1011
DELISTED
NIC Inc
EGOV
| $1.48M | ﹤0.01% |
66,278
-49,667
| -43% | -$1.09M |
|
|
RUTH
1012
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
| $1.48M | ﹤0.01% |
67,930
-209,868
| -76% | -$4.61M |
|
1013
Materion
MTRN
$5.9B
| $1.48M | ﹤0.01% |
24,807
-45,013
| -64% | -$2.66M |
|
1014
Sibanye-Stillwater
SBSW
$7.58B
| $1.47M | ﹤0.01% |
+148,377
| New | +$1.15M |
|
1015
XPO
XPO
$24.5B
| $1.45M | ﹤0.01% |
+52,513
| New | +$1.44M |
|
1016
iShares Core S&P Mid-Cap ETF
IJH
$128B
| $1.44M | ﹤0.01% |
35,000
+9,000
| +35% | +$357K |
|
1017
Orthofix Medical
OFIX
$424M
| $1.44M | ﹤0.01% |
31,164
-82,733
| -73% | -$3.89M |
|
1018
Kraft Heinz
KHC
$29.1B
| $1.44M | ﹤0.01% |
+44,697
| New | +$1.35M |
|
1019
Whirlpool
WHR
$2.79B
| $1.43M | ﹤0.01% |
9,704
+5,668
| +140% | +$856K |
|
1020
Agilysys
AGYS
$3.03B
| $1.42M | ﹤0.01% |
55,992
+13,983
| +33% | +$354K |
|
1021
Evergy
EVRG
$19.2B
| $1.42M | ﹤0.01% |
21,844
-85,659
| -80% | -$5.46M |
|
1022
Marten Transport
MRTN
$1.22B
| $1.41M | ﹤0.01% |
98,714
-252,873
| -72% | -$3.61M |
|
1023
Ulta Beauty
ULTA
$22.9B
| $1.41M | ﹤0.01% |
5,583
-184,936
| -97% | -$45.2M |
|
1024
Newmark Group
NMRK
$2.63B
| $1.4M | ﹤0.01% |
104,267
-282,333
| -73% | -$3.29M |
|
|
EGRX
1025
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $1.4M | ﹤0.01% |
23,336
-31,324
| -57% | -$1.87M |
|
Similar funds
American Century Companies's Q4 2019 Portfolio in Review
As of Q4 2019, American Century Companies held 1,608 positions worth $105B, up 5.4% from $99.6B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
American Century Companies's Q4 2019 filing shows 405 new, 473 increased, 604 reduced and 116 closed positions. Its largest new stake was NXP Semiconductors: 2,360,390 shares worth $300M. The largest sale was iShares Russell 1000 Value ETF, an estimated $339M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.
- American Century Companies's largest Q4 2019 buy was NXP Semiconductors: 2,360,390 shares worth $300M.
- American Century Companies added most to Texas Instruments in Q4 2019, an estimated $416M increase.
- American Century Companies's biggest Q4 2019 reduction was iShares Russell 1000 Value ETF, cutting an estimated $339M.
- American Century Companies fully exited Celgene Corp in Q4 2019, selling an estimated $127M.
- American Century Companies's ten largest holdings make up 19% of its $105B portfolio in Q4 2019.
- American Century Companies opened 405 new positions and closed 116 in Q4 2019.
- American Century Companies's portfolio value rose 5.4% quarter-over-quarter to $105B.
Based on American Century Companies's 13F filing for Q4 2019, filed 12 Feb 2020.